Amlodipine Besylate And Olmesartan Medoxomil Tablet
Product Images NDC 27241-084

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Olmesartan Medoxomil (NDC 27241-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine And Olmesartan 10 20

Label for Amlodipine and Olmesartan Medoxomil Tablets, strength 10 mg/20 mg, in a bottle of 30 tablets. The label includes the NDC number 27241-085-03, manufacturer Ajanta Pharma USA Inc., and storage instructions. The text notes that each tablet contains 13.9 mg Amlodipine Besylate USP equivalent to 10 mg Amlodipine and 20 mg Olmesartan Medoxomil USP.*

FDA Label Image

Amlodipine And Olmesartan 10 40

Label for Amlodipine and Olmesartan Medoxomil tablets, 10 mg/40 mg strength. The label indicates the product contains Amlodipine Besylate equivalent to 10 mg Amlodipine and 40 mg Olmesartan Medoxomil per tablet. It includes storage instructions and marketing information for Ajanta Pharma USA Inc., Bridgewater, NJ, with tablets made in India. The label also has an NDC number 27241-086-03 and space for lot and expiration dates.*

FDA Label Image

Amlodipine And Olmesartan 5 20

Label for Amlodipine and Olmesartan Medoxomil Tablets 5 mg/20 mg by Ajanta Pharma USA Inc. It indicates a package of 30 oral tablets. Storage instructions specify 25°C with permitted excursions to 30°C. The label includes NDC 27241-083-03 and notes the product is made in India.*

FDA Label Image

Amlodipine And Olmesartan 5 40

Label for Amlodipine and Olmesartan Medoxomil Tablets 5 mg/40 mg, containing 30 tablets. The label includes dosage strength, manufacturer Ajanta Pharma USA Inc., storage instructions, and a placeholder for lot and expiration details. The product is for oral use and is a human prescription drug.*

FDA Label Image

Amlodipine And Olmesartan Fig1

A line graph showing the probability of achieving diastolic blood pressure (DBP) below 90 mmHg plotted against baseline DBP (mmHg) for four treatment groups: placebo, Amlodipine 10 mg (AML 10 mg), Olmesartan medoxomil 40 mg (OM 40 mg), and the combination of Amlodipine/Olmesartan 10/40 mg (AML/OM 10/40 mg). Percent DBP < 90 mmHg decreases as baseline DBP increases for all groups, with the combination treatment having the highest probability throughout the range.*

FDA Label Image

Amlodipine And Olmesartan Fig2

A line graph showing the probability of achieving diastolic blood pressure (DBP) < 90 mmHg at week 8 relative to baseline systolic blood pressure (SBP) in mmHg. Four curves represent different treatments: placebo, AML 10 mg, OM 40 mg, and AML/OM 10/40 mg combination. The y-axis shows the percentage with SBP <140 mmHg, and the x-axis shows baseline SBP values from 140 to 180 mmHg.*

FDA Label Image

Amlodipine And Olmesartan Fig3

This line graph shows the probability of achieving diastolic blood pressure (DBP) < 80 mmHg relative to baseline DBP (mmHg) for different treatments: Placebo, AMLODIPINE (AML) 10 mg, OLMESARTAN MEDOXOMIL (OM) 40 mg, and a combination AML/OM 10/40 mg. The vertical axis represents the percentage achieving DBP < 80 mmHg, and the horizontal axis is baseline DBP from 95 to 110 mmHg.*

FDA Label Image

Amlodipine And Olmesartan Fig4

A line graph showing the probability of achieving diastolic blood pressure (DBP) below 80 mmHg at week 8 using LOCF analysis, plotted against baseline systolic blood pressure (SBP) measured in mmHg. The graph compares four groups: Placebo, Amlodipine besylate 10 mg, Olmesartan medoxomil 40 mg, and a combination of Amlodipine besylate 10 mg with Olmesartan medoxomil 40 mg, illustrating higher probabilities with the combination treatment across the SBP range 140 to 180 mmHg.*

FDA Label Image

Amlodipine And Olmesartan1

Chemical structure of amlodipine besylate and olmesartan medoxomil, illustrating the molecular composition and arrangement of the active ingredients in this prescription drug formulation.*

FDA Label Image

Amlodipine And Olmesartan2

Chemical structure diagram of the active ingredient Olmesartan medoxomil, showing its molecular framework with labeled chemical groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.